OCGN Q1 2023 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$443,000

Gross Profit

-$10M-2196.2% margin

Operating Income

-$18M-4071.1% margin

Net Income

-$17M-3911.1% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$96M

Total Liabilities

$20M

Stockholders' Equity

$76M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$443,000	$0	—
Gross Profit	-$10M	$0	—
Operating Income	-$18M	-$18M	-0.0%
Net Income	-$17M	-$18M	+3.8%